2023
Victimization in schizophrenia and its relation to violence
Buchanan A, Stefanovics E, Rosenheck R. Victimization in schizophrenia and its relation to violence. Schizophrenia Research 2023, 255: 52-58. PMID: 36963231, DOI: 10.1016/j.schres.2023.03.018.Peer-Reviewed Original ResearchConceptsIntervention Effectiveness (CATIE) trialMental health symptomsStudy entryCross-sectional designAntipsychotic treatmentEffectiveness trialSchizophrenia symptomsMultivariate analysisHealth symptomsSchizophreniaViolent behaviorSubstance useSymptomsRecent victimizationPotential causesAggressive behaviorChildhood experiencesBaselineMore incidentsCorrelatesTreatmentVictims of violenceSexual abuseClose friendsMost perpetrators
2003
IMPACT OF PUBLIC SUPPORT PAYMENTS, INTENSIVE PSYCHIATRIC COMMUNITY CARE, AND PROGRAM FIDELITY ON EMPLOYMENT OUTCOMES FOR PEOPLE WITH SEVERE MENTAL ILLNESS
RESNICK S, NEALE M, ROSENHECK R. IMPACT OF PUBLIC SUPPORT PAYMENTS, INTENSIVE PSYCHIATRIC COMMUNITY CARE, AND PROGRAM FIDELITY ON EMPLOYMENT OUTCOMES FOR PEOPLE WITH SEVERE MENTAL ILLNESS. The Journal Of Nervous And Mental Disease 2003, 191: 139. DOI: 10.1097/00005053-200303000-00001.Peer-Reviewed Original ResearchIntensive psychiatric community careSevere mental illnessPublic support paymentsMental illnessPsychiatric community careStudy entryControl subjectsClinical trialsCommunity careMultivariate analysisLower likelihoodIllnessProgram fidelityCareOutcomesSignificant interactionEmployment outcomesParticipantsPatientsFidelity of implementationYearsPsychiatricTrials
1998
Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, Henderson W, Charney D. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Health Services Research 1998, 33: 1237-61. PMID: 9865219, PMCID: PMC1070315.Peer-Reviewed Original ResearchConceptsCost-effectiveness ratioRefractory schizophreniaVeterans Affairs Cooperative Study GroupHigh hospital usersIncremental cost-effectiveness ratioDouble-blind trialCooperative Study GroupDisease-specific measuresVA Medical CenterStandard assessment instrumentsMeasures of symptomsMultiple outcome domainsQuality Adjusted Life YearsComposite health indexAdjusted Life YearsHealth indexStudy entryPercent confidence intervalsAverage annual costStandard treatmentCost dataRole functioningStudy groupMedical CenterSide effects